Sign in

Greg Bowman

@drgregbowman.bsky.social
1.9K followers 276 following 98 posts

Scientist. Christ-follower. Prof @UPenn. Director of Folding@home. Legaly blind. Father.

PostsRepliesMedia
Reposted by Greg Bowman
Steve Chalke @stevechalke.bsky.social · 17/09/2025
Hate talk and a Christ-centred life do not, and have never come from the same well.
2275
Greg Bowman @drgregbowman.bsky.social · 09/09/2025
Kitten cage match!
040
Reposted by Greg Bowman
Vittorio Saggiomo @vsaggiomo.bsky.social · 03/09/2025
such an amazing documentary: www.youtube.com/watch?v=GfH4...
youtube.com
Python: The Documentary | An origin story
YouTube video by CultRepo (formerly Honeypot)
282
Reposted by Greg Bowman
pissed-off-g.bsky.social @pissed-off-g.bsky.social · 03/09/2025
158106162314
Greg Bowman @drgregbowman.bsky.social · 31/08/2025
Being ridiculously cute is exhausting!
030
Reposted by Greg Bowman
Hookcity - 🚫“War Plan” DMs Please 👊🏻🇺🇸🔥 🫣 @hookcity.bsky.social · 22/08/2025
Night Sky on Mars #nasadailyupdates
29452541205
Reposted by Greg Bowman
Magnetic Resonance News @nmr900.bsky.social · 05/08/2025
Adriatic NMR Conference, with workshop: NMR Wine Profiling, September 18–20, 2025, Vodice, Croatia adriatic-nmr-conference.hkd.hr #NMRevents #NMRchat #NMR 🧲
adriatic-nmr-conference.hkd.hr
Adriatic NMR 2025
Adriatic NMR Conference 2025. Adriatic NMR Conference will take place at Imperial Park Hotel, Vodice, Croatia, from 18 to 20 September 2025.
022
Reposted by Greg Bowman
Eric Topol @erictopol.bsky.social · 03/08/2025
A rundown on the big advances we’re seeing on the brain-immune axis erictopol.substack.com/p/our-braini...
erictopol.substack.com
Our Brain—Immune Axis Gets A Jolt
Facts, data and analytics about biomedical matters
1325682
Reposted by Greg Bowman
Cecilia Clementi @cecclementi.bsky.social · 18/07/2025
Our development of machine-learned transferable coarse-grained models in now on Nat Chem! doi.org/10.1038/s415... I am so proud of my group for this work! Particularly first authors Nick Charron, Klara Bonneau, Aldo Pasos-Trejo, Andrea Guljas.
doi.org
Navigating protein landscapes with a machine-learned transferable coarse-grained model - Nature Chemistry
The development of a universal protein coarse-grained model has been a long-standing challenge. A coarse-grained model with chemical transferability has now been developed by combining deep-learning m...
57217
Reposted by Greg Bowman
Frank Noe @franknoe.bsky.social · 10/07/2025
BioEmu now published in @science.org !! What is BioEmu? Check out this video: youtu.be/LStKhWcL0VE?...
science.org
Scalable emulation of protein equilibrium ensembles with generative deep learning
Following the sequence and structure revolutions, predicting functionally relevant protein structure changes at scale remains an outstanding challenge. We introduce BioEmu, a deep learning system that...
69128
Greg Bowman @drgregbowman.bsky.social · 07/07/2025
Fossilized coral I found at the beach by Calvert Cliffs. Highly recommend!
120
Greg Bowman @drgregbowman.bsky.social · 04/07/2025
Hosts fireworks 😀
020
Greg Bowman @drgregbowman.bsky.social · 02/07/2025
Made this cat beaker for my science and cat loving 9yo😀
2262
Reposted by Greg Bowman
findlatergroup.bsky.social @findlatergroup.bsky.social · 27/06/2025
🚨JOB ALERT🚨 open rank position in Biochemistry apply now: aprecruit.ucmerced.edu/JPF01995 #ChemSky do your thing, repost please!
aprecruit.ucmerced.edu
Assistant, Associate, or Full Professor in BioChemistry
University of California, Merced is hiring. Apply now!
0107
Reposted by Greg Bowman
Folding@home @foldingathome.org · 26/06/2025
Excited to share about new experimental structures of the coronavirus spike protein that confirm predictions we made early during the COVID-19 pandemic! Congrats to former student Max Zimmerman and the rest of the team at Generate Bio foldingathome.org/2025/06/26/e...
0114
Greg Bowman @drgregbowman.bsky.social · 16/06/2025
Look what my lab got me for Father’s Day!
1101
Greg Bowman @drgregbowman.bsky.social · 10/06/2025
Before and after for my latest gardening project (I build walls, Angela plants things)
080
Reposted by Greg Bowman
Xuhui Huang @xuhuihuangchem.bsky.social · 10/06/2025
Excited to share our latest paper on @natcomputsci.nature.com‬! We present MEMnets, a deep learning framework for coarse-graining protein dynamics, driven by an analytical statistical mechanics theory to minimize memory kernels. Congratulations to all the authors! @uwmadisonchem.bsky.social
193
Reposted by Greg Bowman
C&EN (Chemical & Engineering News) @cenmag.bsky.social · 06/04/2025
Antiviral unveiled that goes after multiple coronaviruses: Open-science consortium discloses its lead candidate to fight SARS-CoV-2 and MERS-CoV. cen.acs.org/acs-news/acs...
cen.acs.org
Antiviral unveiled that goes after multiple coronaviruses
Open-science consortium discloses its lead candidate to fight SARS-CoV-2 and MERS-CoV
1327
Greg Bowman @drgregbowman.bsky.social · 01/04/2025
Its too hard to tell what's real right now for April Fools' jokes to sound fun...
010
Reposted by Greg Bowman
Xuhui Huang @xuhuihuangchem.bsky.social · 26/03/2025
Just one week left! Please consider submitting an abstract to our Pacifichem 2025 @pacifichem.bsky.social symposium on machine learning for biomolecular dynamics. Deadline: April 2!
032
Reposted by Greg Bowman
Caroline Lynn Kamerlin ☀️ @lynnkamerlin.bsky.social · 20/03/2025
Our latest paper "Enzyme Enhancement Through Computational Stability Design Targeting NMR-Determined Catalytic Hotspots" now out in JACS @jacs.acspublications.org. Collaboration with Jose M. Sanchez-Ruiz in Granada, among others. pubs.acs.org/doi/full/10....
pubs.acs.org
Enzyme Enhancement Through Computational Stability Design Targeting NMR-Determined Catalytic Hotspots
Enzymes are the quintessential green catalysts, but realizing their full potential for biotechnology typically requires improvement of their biomolecular properties. Catalysis enhancement, however, is often accompanied by impaired stability. Here, we show how the interplay between activity and stability in enzyme optimization can be efficiently addressed by coupling two recently proposed methodologies for guiding directed evolution. We first identify catalytic hotspots from chemical shift perturbations induced by transition-state-analogue binding and then use computational/phylogenetic design (FuncLib) to predict stabilizing combinations of mutations at sets of such hotspots. We test this approach on a previously designed de novo Kemp eliminase, which is already highly optimized in terms of both activity and stability. Most tested variants displayed substantially increased denaturation temperatures and purification yields. Notably, our most efficient engineered variant shows a ∼3-fold enhancement in activity (kcat ∼ 1700 s–1, kcat/KM ∼ 4.3 × 105 M–1 s–1) from an already heavily optimized starting variant, resulting in the most proficient proton-abstraction Kemp eliminase designed to date, with a catalytic efficiency on a par with naturally occurring enzymes. Molecular simulations pinpoint the origin of this catalytic enhancement as being due to the progressive elimination of a catalytically inefficient substrate conformation that is present in the original design. Remarkably, interaction network analysis identifies a significant fraction of catalytic hotspots, thus providing a computational tool which we show to be useful even for natural-enzyme engineering. Overall, our work showcases the power of dynamically guided enzyme engineering as a design principle for obtaining novel biocatalysts with tailored physicochemical properties, toward even anthropogenic reactions.
44013
Reposted by Greg Bowman
Flatiron Institute @flatironinstitute.org · 19/03/2025
#FlatironCCB scientist @sonyahanson.bsky.social was a guest editor for the Journal of Physical Chemistry B's new Membrane Protein Simulations Special Issue. Read here: pubs.acs.org/toc/jpcbfk/1... #science #biology
Visual graphic of membrane protein simulation
0184
Reposted by Greg Bowman
Denis Wirtz @deniswirtz.bsky.social · 13/03/2025
"Funding from the NIH was contributed to 354 of 356 drugs (99.4%) approved from 2010 to 2019 totaling $187 billion" Reference: jamanetwork.com/journals/jam...
15530
Reposted by Greg Bowman
Prof. F.L. Gervasio Research Group @gervasiolab.bsky.social · 12/03/2025
Very proud of our new review article on the Beta 1-Adrenergic GPCR now available on bioRxiv: www.biorxiv.org/content/10.1.... With @saureli.bsky.social @valeriorizzi.bsky.social and Nicola we used OneOPES to fully converge the free energy landscapes associated with B1AR apo/holo activation.
0147
Reposted by Greg Bowman
Richard Sever @richardsever.bsky.social · 11/03/2025
Big news: we are setting up a new non-profit organization to run bioRxiv and medRxiv. It's called openRxiv [no it's not a new preprint server; it's dedicated organization to oversee the servers] openrxiv.org 1/n
openrxiv.org
Homepage - openRxiv
openRxiv is an independent non-profit, the new organizational home for bioRxiv and medRxiv, enabling researchers to instantly share groundbreaking findings with the global scientific community.
552558846
Reposted by Greg Bowman
Sukrit Singh @sukritsingh92.bsky.social · 10/03/2025
This work is now published in J Phys Chem B! Check out our work showing that simulations predict the impact of distal mutations on kinase-inhibitor binding, and our experimental NanoBRET dataset of 94 kinase mutations that provide a benchmark for future methods. Link: pubs.acs.org/doi/full/10....
Illustration showing a pipeline for predicting the impact of ABL1A kinase domain mutations on inhibitor binding. On the left, icons labeled 'Physics-based simulations' and 'Data-driven methods' feed into 'Prospective ΔΔG Predictions.' On the right, a 3D ribbon model of the ABL1A kinase domain (gray) highlights clinically observed mutations in orange and an inhibitor in blue.
0299
Reposted by Greg Bowman
Eric Topol @erictopol.bsky.social · 10/03/2025
99% of new medicines developed by the pharmaceutical industry depend on NIH research jamanetwork.com/journals/jam...
jamanetwork.com
Comparison of Research Spending on New Drug Approvals by the NIH vs the Pharmaceutical Industry
This cross-sectional study examines National Institutes of Health and pharmaceutical industry investments in recent drug approvals.
18884437
Reposted by Greg Bowman
Jonathan Wosen @jonathanwosen.bsky.social · 05/03/2025
Breaking news: A judge has issued a national preliminary injunction blocking Trump cuts to NIH research overhead payments, a decision that suggests plaintiffs seeking to overturn the policy change are likely to eventually succeed. My latest for @statnews.com www.statnews.com/2025/03/05/n...
statnews.com
Judge issues preliminary injunction blocking Trump cuts to NIH research overhead payments
A federal judge issued a nationwide preliminary injunction blocking the Trump administration from slashing NIH payments for research overhead
0122
Reposted by Greg Bowman
Stand Up for Science! @standupforscience.net · 05/03/2025
2 DAYS until we STAND UP FOR SCIENCE! More information on local sites available at www.standupforscience2025.org ☀️ #standupforscience2025
Navy background with white text that says "2 days until stand up for science"
5347144
Reposted by Greg Bowman
Folding@home @foldingathome.org · 04/03/2025
Please join us as we Stand Up for Science in cities across the US on Friday March 7. You can find more details on the main event in Washington DC and your local event at standupforscience2025.org
0104
Reposted by Greg Bowman
Samuel Sledzieski @samsl.io · 03/03/2025
Seq2Symm is out now in @naturecomms.bsky.social! PLMs continue to be unreasonably efficient-- even for highly divergent sequences. Meghana and Minkyung did a great job leading on this! 📄: www.nature.com/articles/s41... 💻: github.com/microsoft/se...
nature.com
Rapid and accurate prediction of protein homo-oligomer symmetry using Seq2Symm - Nature Communications
Seq2Symm is a sequence-based AI model designed to predict the symmetry of protein structures composed of identical chains, known as homo-oligomers. It surpasses existing methods in accuracy and effici...
173
Reposted by Greg Bowman
Xuhui Huang @xuhuihuangchem.bsky.social · 27/02/2025
Our perspective on using computational tools to design bacterial RNA polymerase inhibitors is out in the "Computational Biochemistry" special issue of ACS Biochemistry. Congratulations to Eshani! pubs.acs.org/doi/full/10....
pubs.acs.org
Targeting Bacterial RNA Polymerase: Harnessing Simulations and Machine Learning to Design Inhibitors for Drug-Resistant Pathogens
The increase in antimicrobial resistance presents a major challenge in treating bacterial infections, underscoring the need for innovative drug discovery approaches and novel inhibitors. Bacterial RNA...
021
Greg Bowman @drgregbowman.bsky.social · 25/02/2025
One of the highlights of my life right now is snuggling with my 8yo while reading books😀🥰
030
Reposted by Greg Bowman
Gabriela K Popescu @popstarlab.bsky.social · 24/02/2025
Guidance given to hostages can foster psychological flexibility in tough times. ▪︎ Choose your attitude and actions, even in difficult circumstances. ▪︎ Maintain self-discipline and mental stimulation so you are ready for the next step. ▪︎Plan for a better future to maintain hope.
psychologytoday.com
In Tumultuous Times, Think Like a Hostage
Feeling like a hostage? Learn psychological strategies from POWs and hostages to maintain resilience, resist despair, and plan for a brighter future in these turbulent times.
1104
Reposted by Greg Bowman
Frank Noe @franknoe.bsky.social · 21/02/2025
Today we have published BioEmu-Benchmarks (MIT license): a code to evaluate the multi-conformation sampling benchmarks, MD free energy landscape benchmarks, and folding free energy benchmarks shown in the BioEmu-1 paper with BioEmu or your own model. Some details below 🧵 github.com/microsoft/bi...
github.com
GitHub - microsoft/bioemu-benchmarks: Benchmarking code accompanying the release of `bioemu`
Benchmarking code accompanying the release of `bioemu` - microsoft/bioemu-benchmarks
47521
Greg Bowman @drgregbowman.bsky.social · 21/02/2025
There can still be joy!
120
Greg Bowman @drgregbowman.bsky.social · 20/02/2025
Great time at #bps2025 and now it’s great to be home😀
2100
Reposted by Greg Bowman
Sonya @sonyahanson.bsky.social · 17/02/2025
We are hiring a Flatiron Research Fellow in the Structural Molecular Biophysics team! Experience with cryoEM and/or membrane protein simulations are a plus! Happy to chat in person with anyone at #bps2025 ! apply.interfolio.com/160227
apply.interfolio.com
Apply - Interfolio {{$ctrl.$state.data.pageTitle}} - Apply - Interfolio
13019
Reposted by Greg Bowman
Sukrit Singh @sukritsingh92.bsky.social · 16/02/2025
I'll be presenting my work prospectively studying clinical mutations and their impact on kinase inhibitor binding at #bps2025! Come see my talk on Wednesday morning @ 8:45am.
1359
Greg Bowman @drgregbowman.bsky.social · 16/02/2025
Nice time catching up with folks from @foldingathome.org at #bps2025
1294
Reposted by Greg Bowman
Greg Bowman @drgregbowman.bsky.social · 13/02/2025
Three talks from my group on Sunday at #BPS2025 Cryptic pockets in crowded environments 9:30am in Rm 502A Allosteric glues inhibit G proteins noon in Rm 515B Antibody dynamics 5:30pm in Rm 502A
0173
Reposted by Greg Bowman
Stand Up for Science! @standupforscience.net · 12/02/2025
Welcome to the Bluesky account for Stand Up for Science 2025! Keep an eye on this space for updates, event information, and ways to get involved. We can't wait to see everyone #standupforscience2025 on March 7th, both in DC and locations nationwide! #scienceforall #sciencenotsilence
289114575402
Greg Bowman @drgregbowman.bsky.social · 13/02/2025
Three talks from my group on Sunday at #BPS2025 Cryptic pockets in crowded environments 9:30am in Rm 502A Allosteric glues inhibit G proteins noon in Rm 515B Antibody dynamics 5:30pm in Rm 502A
0173
Reposted by Greg Bowman
Andrea Love, PhD | Biomedical Scientist @drandrealove.bsky.social · 12/02/2025
Nearly every medicine we benefit from started with NIH-funded research. Early discovery work starts in academia. Immunotherapies? Gene therapy for rare diseases? Alzheimer’s and Parkinson’s medicines? Vaccines? Novel cancer treatments? Psychiatric medicines? You betcha. 1/
8545711033
Reposted by Greg Bowman
Mark Cuban @mcuban.bsky.social · 09/02/2025
This is the most relevant article to NIH and research cuts I’ve seen. Imagine if this was today , how many people would be saying “Why are we studying Gila Monsters and their impact on diabetes ? That’s wasted money !” globalnews.ca/news/9793403...
globalnews.ca
How a Canadian scientist and a venomous lizard helped pave the way for Ozempic - National | Globalnews.ca
In 1984, Dr. Daniel Drucker, an endocrinologist from the University of Toronto, discovered a hormone that helped pave the way for popular diabetes drugs such as Ozempic.
11264858712423
Greg Bowman @drgregbowman.bsky.social · 10/02/2025
It was fun watching the Eagles crush the Chiefs last night😀
000
Greg Bowman @drgregbowman.bsky.social · 06/02/2025
Cool😀
171
Greg Bowman @drgregbowman.bsky.social · 06/02/2025
Trying to focus on the fact that I GET to do science today
0100